Literature DB >> 10466742

Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines.

N Oda1, K Minoguchi, T Yokoe, T Hashimoto, K Wada, M Miyamoto, A Tanaka, Y Kohno, M Adachi.   

Abstract

Suplatast tosilate (IPD-1151T) is an antiallergic agent that suppresses airway eosinophil infiltration in asthma. We investigated the effects of IPD-1151T on proliferative response and cytokine production by human antigen-specific T cell lines. Purified protein derivatives (PPD)-specific T helper 1 (Th1) cell lines and Dermatophagoides farinae (Der f)-specific T helper 2 (Th2) cell lines were established from patients with asthma sensitized with house dust mite. Stimulation of PPD-specific and Der f-specific T cell lines with relevant antigens resulted in production of mostly interferon (IFN)-gamma and of interleukin (IL)-4 and IL-5, respectively. IPD-1151T did not inhibit the proliferative responses of either the Th1 or Th2 cell line to antigens. Although IPD-1151T did not inhibit IFN-gamma production by PPD-specific Th1 cell lines, it did inhibit IL-4 and IL-5 production by antigen-stimulated Der f-specific Th2 cell lines in a dose-dependent manner. IPD-1151T directly inhibited cytokine production by Der f-specific Th2 cell lines stimulated with immobilized anti-CD3 antibodies. Although IPD-1151T did not inhibit the clonal expansion of memory T cells among PBMCs into PPD-specific Th1 and Th2 cell lines, it did inhibit IL-4 and IL-5 production by Der f-specific Th2 cell lines but not IFN-gamma production by PPD-specific Th1 cell lines. These results suggest that IPD-1151T selectively inhibits Th2-type cytokine production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466742     DOI: 10.1016/s0024-3205(99)00303-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.

Authors:  M Kurokawa; K Kawazu; K Asano; K Fumio; A Mita; M Adachi
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

3.  The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.

Authors:  K Asano; T Mizutani; T Shimane; M Hisano; T Hisamitsu; H Suzaki
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

4.  Small molecule-directed immunotherapy against recurrent infection by Mycobacterium tuberculosis.

Authors:  Debapriya Bhattacharya; Ved Prakash Dwivedi; Mamoudou Maiga; Mariama Maiga; Luc Van Kaer; William R Bishai; Gobardhan Das
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.